trusight rapid (Illumina Inc)
Illumina Inc is a verified supplier 
96
Structured Review
Illumina Inc
trusight rapid
Trusight Rapid, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 82 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight+rapid/TruSight+Rapid+Capture/pm41826624-72-4-19
Average 96 stars, based on 82 article reviews
Trusight Rapid, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 82 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trusight+rapid/TruSight+Rapid+Capture/pm41826624-72-4-19
Average 96 stars, based on 82 article reviews
trusight rapid - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Sequencing:Article Title: Detecting monogenic obesity: a systematic exome-wide workup of over 500 individuals Article Snippet: Sequencing was performed on Illumina NovaSeq 6000 (TWIST, TWIST 2.0), BGISEQ-500 (BGI), or an Illumina NextSeq- or HighSeq platform (Nextera, Agilent). .. The remaining 15.3% of patients ( n = 81) received genetic diagnostics based on the TruSight One Sequencing Panel (4,813 genes, Supplementary Table ), using the Article Title: Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice. Article Snippet: Purpose The implementation of the next-generation sequencing (NGS) in clinical practice has improved the genetic diagnosis of Hereditary Breast and Ovarian Cancer Syndrome (HBOC).. We aimed to evaluate the diagnostic outcomes of using an NGS cancer gene panel in clinical practice for patients selected based on personal and/or family history of breast, ovarian, prostate, melanoma, and other HBOC-associated cancers.. Methods The study series included 2561 consecutive Spanish individuals referred for genetic testing, comprising 2445 cancer patients and 116 healthy individuals with family history of HBOC. Article Title: Detecting monogenic obesity: a systematic exome-wide workup of over 500 individuals. Article Snippet: Sequencing was performed on Illumina NovaSeq 6000 (TWIST, TWIST 2.0), BGISEQ-500 (BGI), or an Illumina NextSeq- or HighSeq platform (Nextera, Agilent). .. The remaining 15.3% of patients (n= 81) received genetic diagnostics based on the TruSight One Sequencing Panel (4,813 genes, Supplementary Table 1), using the Article Title: Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study Article Snippet: DNA were extracted from peripheral blood samples using the Magnapure 96 system (Roche, Indianapolis, IN). .. Next-generation sequencing (NGS) libraries were prepared using the Article Title: Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study. Article Snippet: DNA were extracted from peripheral blood samples using the Magnapure 96 system (Roche, Indianapolis, IN). .. Nextgeneration sequencing (NGS) libraries were prepared using the Article Title: The Relationship of the Pathogenic Variant rs721048 in the Intron of the EHBP1 Gene with the Development of Prostate Cancer and Colorectal Cancer in the Kazakh Population. Article Snippet: Libraries from the obtained DNA were prepared using the Illumina DNA Prep kit. .. Enrichment was performed using the other:Article Title: Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high-grade serous ovarian cancer. Article Snippet: Genomic DNA was isolated from OV-MZ-6 and Kuramochi cells. Next-Generation Sequencing:Article Title: Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice. Article Snippet: Purpose The implementation of the next-generation sequencing (NGS) in clinical practice has improved the genetic diagnosis of Hereditary Breast and Ovarian Cancer Syndrome (HBOC).. We aimed to evaluate the diagnostic outcomes of using an NGS cancer gene panel in clinical practice for patients selected based on personal and/or family history of breast, ovarian, prostate, melanoma, and other HBOC-associated cancers.. Methods The study series included 2561 consecutive Spanish individuals referred for genetic testing, comprising 2445 cancer patients and 116 healthy individuals with family history of HBOC. Article Title: Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study Article Snippet: DNA were extracted from peripheral blood samples using the Magnapure 96 system (Roche, Indianapolis, IN). .. Next-generation sequencing (NGS) libraries were prepared using the Article Title: Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study. Article Snippet: DNA were extracted from peripheral blood samples using the Magnapure 96 system (Roche, Indianapolis, IN). .. Nextgeneration sequencing (NGS) libraries were prepared using the |